Actions taken by federal agencies in response to President Biden’s executive ord...
La "paradoja hispana" intriga a una nueva generación de investigadores decididos...
Want to stay on top of the science and politics driving biotech today? Sign up t...
Sarepta said its gene therapy for Duchenne muscular dystrophy failed to improve ...
The US Food and Drug Administration (FDA) has accepted Day One Biopharmaceutica...
Shorla Oncology has acquired the oncology and autoimmune drug Jylamvo (methotre...
SpyGlass Pharma is initiating Phase I/II clinical trials investigating its drug...
The third quarter of 2023 saw a slight fall in deal activity after the recovery ...
Aragen Life Sciences has invested $30m to set up a new biologics manufactur...
The US Food and Drug Administration (FDA) has granted a fast track designation ...
Leading biopharmaceutical companies are reshaping their strategies in light of ...
Sosei Heptares will receive $3.75m from Genentech after it reaches a discovery-...
Roche and Sarepta Therapeutics’ have announced top-line results from the Ph...
ArriVent Biopharma has received the US Food and Drug Administration's (FDA) bre...
The rare moment of levity during the meeting on candy-like drugs came when a den...
Sarepta Therapeutics said Monday afternoon that its gene therapy for Duchenne mu...
